Oral oncolytics
Oral oncolytics: imatinib, pazopanib, sunitinib and desethylsunitinib in serum. A clinical case is presented with the fourth vial to test the clinical advisory skills of the laboratory.
Contactperson
dr. D.M. Kweekel (Coördinator)Frequency
4 rounds of 1 samplesNumber of participants
19Price
Participation
€ 443.97
Additional sample set
€ 206.31
Additional cluster
€ 131.49
Details
Report
This scheme is processed and reported electronically (QBase).
Supported analytes
Cabozantinib |
Desethylsunitinib |
Imatinib |
Olaparib |
Pazopanib |
Sunitinib |
Methodelijst Orale oncolytica
Cabozantinib | Consensus methodegroep |
---|---|
HPLC-MS/UPLC-MS/MS-detectie | MS-detectie |
HPLC-UV | Overige methodes |
Overigen | Overige methodes |
Desethylsunitinib | Consensus methodegroep |
---|---|
HPLC-MS/UPLC-MS/MS-detectie | MS-detectie |
HPLC-UV | Overige methodes |
Overigen | Overige methodes |
Imatinib | Consensus methodegroep |
---|---|
HPLC-MS/UPLC-MS/MS-detectie | MS-detectie |
HPLC-UV | Overige methodes |
Overigen | Overige methodes |
Olaparib | Consensus methodegroep |
---|---|
HPLC-MS/UPLC-MS/MS-detectie | MS-detectie |
HPLC-UV | Overige methodes |
Overigen | Overige methodes |
Pazopanib | Consensus methodegroep |
---|---|
HPLC-MS/UPLC-MS/MS-detectie | MS-detectie |
HPLC-UV | Overige methodes |
Sunitinib | Consensus methodegroep |
---|---|
HPLC-MS/UPLC-MS/MS-detectie | MS-detectie |
HPLC-UV | Overige methodes |
Questions about this scheme?
Use the form below to send us a message.
"*" indicates required fields